pyrazines has been researched along with Asymptomatic Conditions in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amin, EK; Austin, ED; Colglazier, E; Fineman, JR; Hemnes, AR; Leary, PJ; Nawaytou, H; Parker, C; Teitel, D | 1 |
| Banno, S; Doi, Y; Hase, R; Hibino, M; Hirose, M; Homma, Y; Horiguchi, T; Ikeda, N; Imai, T; Iwata, M; Kabata, D; Kamio, T; Kasahara, H; Kasamatsu, Y; Kashizaki, F; Kato, H; Kato, Y; Kita, T; Koba, H; Kodama, N; Kondo, M; Koseki, T; Lim, CK; Maeki, T; Matsuyama, A; Miyata, M; Mutoh, Y; Nakagawa, A; Nakatsumi, H; Nakayama, E; Ogawa, T; Saijo, M; Shinoda, M; Shintani, A; Tajima, S; Taniguchi, S; Terada, M; Teramachi, M; Uchida, Y; Yamamoto, M; Yokota, K; Yokoyama, T; Yoshida, H; Yoshida, J; Yuzawa, Y | 1 |
| Arnold, WD; Burghes, AHM; Chugh, D; Kray, KM; McGovern, VL | 1 |
1 trial(s) available for pyrazines and Asymptomatic Conditions
| Article | Year |
|---|---|
A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19.
Topics: Adolescent; Adult; Amides; Antiviral Agents; Asymptomatic Diseases; COVID-19; COVID-19 Drug Treatment; Female; Hospitalization; Humans; Hyperuricemia; Japan; Male; Middle Aged; Prospective Studies; Pyrazines; Random Allocation; SARS-CoV-2; Secondary Prevention; Severity of Illness Index; Time-to-Treatment; Treatment Outcome; Viral Load | 2020 |
2 other study(ies) available for pyrazines and Asymptomatic Conditions
| Article | Year |
|---|---|
Novel Documentation of Onset and Rapid Advancement of Pulmonary Arterial Hypertension without Symptoms in BMPR2 Mutation Carriers: Cautionary Tales?
Topics: Acetamides; Adolescent; Antihypertensive Agents; Asymptomatic Diseases; Bone Morphogenetic Protein Receptors, Type II; Cardiac Catheterization; Disease Progression; Dyspnea; Echocardiography; Exercise Tolerance; Female; Genetic Testing; Heterozygote; Humans; Male; Phenylpropionates; Pulmonary Arterial Hypertension; Pyrazines; Pyridazines; Sildenafil Citrate; Syncope; Vasodilator Agents | 2020 |
Dual SMN inducing therapies can rescue survival and motor unit function in symptomatic ∆7SMA mice.
Topics: Action Potentials; Animals; Asymptomatic Diseases; Disease Models, Animal; Mice; Mice, Knockout; Morpholinos; Muscle, Skeletal; Neuromuscular Junction; Oligonucleotides, Antisense; Pyrazines; Pyrimidines; Spinal Muscular Atrophies of Childhood; Survival of Motor Neuron 1 Protein | 2021 |